Cargando…
Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918909/ https://www.ncbi.nlm.nih.gov/pubmed/36770166 http://dx.doi.org/10.3390/ma16031156 |
_version_ | 1784886692643078144 |
---|---|
author | Abdel-Mottaleb, Mona M. A. Boi, Lorenza Barra, Marina Colin, Julie Berni, Luisa Béduneau, Arnaud Moulari, Brice Pellequer, Yann |
author_facet | Abdel-Mottaleb, Mona M. A. Boi, Lorenza Barra, Marina Colin, Julie Berni, Luisa Béduneau, Arnaud Moulari, Brice Pellequer, Yann |
author_sort | Abdel-Mottaleb, Mona M. A. |
collection | PubMed |
description | Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers makes them suitable for drug delivery purposes. Here, we investigate the effect of lipoproteins’ intricate composition on the entrapment efficiency of a model drug “Cyclosporine A” into the different types of lipoproteins, namely, HDL, LDL and VLDL. It was observed that the protein content of the lipoproteins had the highest effect on the entrapment of the drug with a correlation coefficient of 0.80, 0.81 and 0.96 for HDL, LDL and VLDL respectively. This was even confirmed by the effect of plasma on the association rate of lipoproteins and the drug. The second effective factor is the cholesterol concentration, while triglycerides and phospholipids had a negligible effect. |
format | Online Article Text |
id | pubmed-9918909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99189092023-02-12 Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment Abdel-Mottaleb, Mona M. A. Boi, Lorenza Barra, Marina Colin, Julie Berni, Luisa Béduneau, Arnaud Moulari, Brice Pellequer, Yann Materials (Basel) Communication Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers makes them suitable for drug delivery purposes. Here, we investigate the effect of lipoproteins’ intricate composition on the entrapment efficiency of a model drug “Cyclosporine A” into the different types of lipoproteins, namely, HDL, LDL and VLDL. It was observed that the protein content of the lipoproteins had the highest effect on the entrapment of the drug with a correlation coefficient of 0.80, 0.81 and 0.96 for HDL, LDL and VLDL respectively. This was even confirmed by the effect of plasma on the association rate of lipoproteins and the drug. The second effective factor is the cholesterol concentration, while triglycerides and phospholipids had a negligible effect. MDPI 2023-01-29 /pmc/articles/PMC9918909/ /pubmed/36770166 http://dx.doi.org/10.3390/ma16031156 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Abdel-Mottaleb, Mona M. A. Boi, Lorenza Barra, Marina Colin, Julie Berni, Luisa Béduneau, Arnaud Moulari, Brice Pellequer, Yann Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title | Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title_full | Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title_fullStr | Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title_full_unstemmed | Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title_short | Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment |
title_sort | lipoproteins as drug carriers for cyclosporine a: optimization of the entrapment |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918909/ https://www.ncbi.nlm.nih.gov/pubmed/36770166 http://dx.doi.org/10.3390/ma16031156 |
work_keys_str_mv | AT abdelmottalebmonama lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT boilorenza lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT barramarina lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT colinjulie lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT berniluisa lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT beduneauarnaud lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT moularibrice lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment AT pellequeryann lipoproteinsasdrugcarriersforcyclosporineaoptimizationoftheentrapment |